Diagnosis (2019 documentary): Rasmussen’s Encephalitis (Episode 2 Review)
- Feb 16
- 5 min read
Imagine being the parent of a vibrant, "unstoppable" seven-year-old girl who suddenly begins to suffer a seizure every few minutes. Now, imagine being told that the only way to save her brain from slowly destroying itself is to cut half of it out—leaving her permanently paralyzed on one side. This was the impossible, heart-shattering choice facing the parents of Sadie Hana Gonzalez.
In the second episode of the Netflix documentary Diagnosis, titled "Second Opinions," Dr. Lisa Sanders explores the terrifying world of Rasmussen’s Encephalitis. The episode is a masterclass in the agony of medical decision-making, pitting a "standard of care" that feels medieval against a high-tech, experimental alternative. This case review breaks down Sadie’s journey from a "Super Sadie" in Queens, New York, to a pioneering "cyborg" patient, dissecting the crowd’s theories and the clinical pivot that saved her mobility.
Patient Profile
Patient: Sadie Hana Gonzalez
Age: 7 years old
Location: Queens, New York
Presenting Complaint: Sudden onset of focal motor seizures (twitching of the mouth, spasms in the leg) occurring every few minutes, resistant to anti-seizure medication.
The Clinical Mystery
Sadie was a healthy, bubbly child—affectionately nicknamed "Super Sadie" for her resilience—until the seizures began. Unlike the violent, full-body convulsions often depicted in media, Sadie’s seizures were focal. Her mouth would twitch uncontrollably; her leg would jerk, knocking her to the ground. Yet, she remained conscious, often trying to laugh off the terrifying interruptions to her childhood.
Her initial medical team in New York arrived at a devastating conclusion: Rasmussen’s Encephalitis (RE). This rare, progressive inflammatory disease causes the immune system to attack one hemisphere of the brain. The standard treatment is a hemispherectomy—a radical surgery to disconnect or remove the affected half of the brain. While it stops the seizures, it guarantees hemiplegia (paralysis on one side) and vision loss. Unwilling to accept this "barbaric" outcome without a fight, Sadie’s parents turned to Dr. Sanders and the crowd for any other explanation.
Second Opinions: Differential Diagnoses
Dr. Lisa Sanders’ column in the New York Times broadcast Sadie’s symptoms to the world. The "wisdom of the crowd" generated a flood of theories, many attempting to find a cause that wasn't Rasmussen's. Below is a structured review of the differential diagnoses discussed, listed in order of mention:
Brain Tumor: Early imaging (MRI) was used to rule out masses. Status: Ruled out immediately; no tumor was found.
Stroke: The sudden onset mimicked a cerebrovascular event. Status: Ruled out via MRI; blood flow was normal.
Infection or Autoimmune Disease: A spinal tap checked for active viral/bacterial infections or standard autoimmune antibodies. Status: Initially negative, ruling out common causes like meningitis or classic autoimmune encephalitis.
Bartonella: A contributor suggested this pathogen (spread by fleas/ticks) could cause neurological symptoms. Status: Considered as part of the "stealth infection" theory but not the primary driver.
Metabolic Irregularities: Crowd submissions noted potential glucose and amino acid fluctuations. Status: Investigated but deemed non-contributory to the focal structural pathology.
Lyme Disease: The most significant "red herring." A large portion of the crowd, including a physician, urged testing for Lyme. Status: Sadie tested positive and underwent six weeks of antibiotics. However, her seizures worsened during treatment, suggesting the Lyme was either a past infection (incidental finding) or not the cause of the encephalopathy.
The Turning Point: A "Pacemaker" for the Brain
The breakthrough did not come from a new diagnosis, but from a new perspective on the existing one. Sadie’s parents sought a second opinion at Mount Sinai Hospital with neurologist Dr. Lara Marcuse and neurosurgeon Dr. Saadi Ghatan.
Dr. Ghatan noted a critical discrepancy: while Sadie’s brain biopsy showed the inflammation typical of encephalitis, her MRI did not show the severe brain shrinkage (atrophy) usually seen in advanced Rasmussen’s. Her brain was still physically intact. This opened the door for a third option between "do nothing" and "remove half the brain."
The team proposed implanting a Responsive Neurostimulation (RNS) device.
The Diagnosis: Rasmussen’s Encephalitis (Early Stage)
Diagnosis: Rasmussen’s Encephalitis (RE)
Pathophysiology:
RE is a chronic, progressive inflammation of one cerebral hemisphere. T-lymphocytes (white blood cells) infiltrate the brain tissue, attacking neurons and astrocytes. This leads to epilepsia partialis continua (constant focal seizures) and eventually liquefies the brain tissue, leaving a hollowed-out hemisphere.
Etymology:
Rasmussen: Named after neurosurgeon Theodore Rasmussen, who first described the condition in 1958 at the Montreal Neurological Institute.
Encephalitis: From the Greek en (in) + kephalē (head) + itis (inflammation).
Treatment and Standard of Care
The "Alternative" Treatment: Sadie underwent surgery to implant the RNS System (NeuroPace).
Mechanism: The device involves placing leads (wires) directly on the seizure "hot spots" in the brain. The device monitors electrical activity 24/7. When it detects the specific pattern of a seizure starting, it fires a counter-stimulation pulse to "short-circuit" the seizure before it spreads.
Sadie’s Reaction: She famously referred to the implant as a "computer chip" and proudly called herself a "cyborg."
Current Standard of Care (2025):
Hemispherectomy: Remains the gold standard for advanced Rasmussen’s where atrophy is already present and function is lost. It offers the highest cure rate for seizures.
Immunotherapy: (Tacrolimus, IVIG, Rituximab) is often used to slow progression in the early stages.
Neuromodulation (RNS/VNS): As seen in Sadie’s case, this is increasingly used as a palliative or "bridge" therapy to preserve function for as long as possible, or as a long-term solution for patients who do not fit the classic atrophy profile.
Patient Update (2025)
Sadie’s outcome has been a beacon of hope for families facing RE. Following the surgery, her seizure frequency dropped dramatically.
Clinical Status: As of the last major update from Mount Sinai (2022), the RNS device was successfully managing her condition. The "heavy fog" of constant seizures lifted, allowing her cognitive development to proceed on track.
Life: She returned to school and resumed being a "force of nature." While RNS is not technically a "cure" (the underlying propensity for seizures remains), it effectively manages the symptoms without the devastating trade-off of paralysis.
Current Outlook: She continues to be monitored by her team at Mount Sinai, representing a new generation of patients managing RE with technology rather than amputation.
Key Takeaways
🗝️ Anatomy vs. Function: The pivotal clue was the lack of atrophy on the MRI. Because Sadie’s brain tissue was still physically there (unlike in late-stage Rasmussen’s), the surgeons reasoned it was worth saving.
🗝️ The Lyme Red Herring: A positive test doesn't always equal a diagnosis. Sadie had Lyme antibodies, but treating it didn't stop the seizures. This highlights the danger of "finding what you look for" in complex cases.
🗝️ Technology Over Radical Surgery: The move from hemispherectomy (removing half the brain) to RNS (implanting a chip) represents a massive paradigm shift in neurology—moving from resection (cutting out) to modulation (tuning).
🗝️ The "Cyborg" Future: Sadie’s acceptance of her device as a "superpower" illustrates the resilience of pediatric patients. The RNS device allows the brain to "teach itself" to stop seizures.
🗝️ Second Opinions Save Lives: If Sadie’s parents had accepted the first expert opinion, Sadie would be paralyzed on one side today. The "wisdom of the crowd" in this episode was less about a specific diagnosis and more about the empowerment to seek better options.
Keywords: Diagnosis Episode 2 Review
Diagnosis Episode 2 Review
Comments